Patrick Rivers

Private Equity Investor at

aMoon Ventures Y Sh Ltd.

Health Technology

Consumer Services

Finance

Profile

Patrick Rivers worked at XOMA Royalty Corp.
as a Process Development Associate in 2009.
Mr. Rivers worked at Exelixis, Inc. as an Associate Research Scientist in 2011.
Mr. Rivers worked at Sutro Biopharma, Inc. as a Senior Research Associate in 2014.
Mr. Rivers worked at Aquilo Capital Management LLC from 2014 to 2024, serving as Managing Director & Head of Research from 2019 to 2024.
Mr. Rivers completed an undergraduate degree at the University of California, Los Angeles in 2005.
Mr. Rivers earned an MBA from Haas School of Business in 2016.

Patrick Rivers active positions

Companies	Position	Start
aMoon Ventures Y Sh Ltd. aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor.	Private Equity Investor	2024-07-31

All active positions of Patrick Rivers

Former positions of Patrick Rivers

Companies	Position	End
Aquilo Capital Management LLC Aquilo Capital Management LLC Investment ManagersFinance Aquilo manages funds that generally focus on the life sciences industry, with a specific focus on biotechnology and drug discovery and development companies. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. Their goal is to provide long- term clients and investors with a high rate of return relative to risk over time.	Director of Research - Equity	2024-07-31
SUTRO BIOPHARMA, INC.	Corporate Officer/Principal	2014-05-31
EXELIXIS, INC.	Corporate Officer/Principal	2010-12-31
XOMA ROYALTY CORPORATION	Corporate Officer/Principal	2008-12-31

See the detail of Patrick Rivers's experience

Training of Patrick Rivers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Rivers's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
XOMA Royalty Corp. XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics	Health Technology
Exelixis, Inc. Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company	Health Technology
Sutro Biopharma, Inc. Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Haas School of Business Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aquilo Capital Management LLC Aquilo Capital Management LLC Investment ManagersFinance Aquilo manages funds that generally focus on the life sciences industry, with a specific focus on biotechnology and drug discovery and development companies. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. Their goal is to provide long- term clients and investors with a high rate of return relative to risk over time.	Finance
aMoon Ventures Y Sh Ltd. aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor.	Finance